Schonfeld Strategic Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,890	Closed	-$15.3K	–	2323
2022 Q4	$15.3K	Sell	1,890 -960	-34%	-$10.4K	﹤0.01%	2338
2022 Q3	$38K	Hold	2,850	–	–	﹤0.01%	2668
2022 Q2	$46K	Sell	2,850 -50	-2%	-$828	﹤0.01%	2233
2022 Q1	$66K	Buy	+2,900	New	+$52K	﹤0.01%	2299
2021 Q1	–	Sell	-4,701	Closed	-$522K	–	1935
2020 Q4	$522K	Buy	+4,701	New	+$508K	0.01%	1025
2020 Q1	–	Sell	-3,707	Closed	-$453K	–	1298
2019 Q4	$453K	Buy	3,707 +20	+0.5%	+$1.7K	0.01%	784
2019 Q3	$276K	Buy	+3,687	New	+$272K	0.01%	810

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Schonfeld Strategic Advisors's HOOK Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 1,890 shares — an estimated $15.3K sold.

Schonfeld Strategic Advisors first reported a position in HOOK in Q3 2019 and held it in 7 quarters. The position peaked at $522K in Q4 2020. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

Schonfeld Strategic Advisors reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 1,890 HOOKIPA Pharma shares in Q1 2023, an estimated $15.3K.
Schonfeld Strategic Advisors first reported a position in HOOKIPA Pharma in Q3 2019 and held it in 7 quarters.
Schonfeld Strategic Advisors's HOOKIPA Pharma position peaked at $522K in Q4 2020.
45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.